Speakers – Autoimmunity

Alan Sacerdote
Department of Medicine, Woodhull Medical Center, Brooklyn, New York, United States
Autoimmunity, Insulin Resistance, and Non-Classic Adrenal Hyperplasia
28-April-2017 : 8:05 – 8:35

Invited Speakers

Ciriaco A. Piccirillo
McGill University, Montreal, Canada
Suppression by Human FOXP3+Treg Cells Requires FOXP3/TIP60 Interaction
28-April-2017 : 8:35 – 8:55

Wen Ming Chu
University of Hawaii Cancer Center, Honolulu, HI, USA
The IKK-NF-κB Axis in DC Homeostasis, Maturation and Function
28-April-2017 : 9:15 – 9:35

Daniel Sánchez
Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic
Autoantibodies To Calreticulin In Patients With Selected Autoimmune Diseases
28-April-2017 : 9:35 – 9:55

Plenary Session

Jeffery V. Ravetch
Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY 10065, USA
28-April-2017 : 9:55 – 10:35

Gregg J. Silverman
NYU School of Medicine, Alexandria Center for Life Science, New York, NY 10016, USA
Autoimmunity And The Microbiome
28-April-2017 : 10:55 – 11:35

Paul L. Bollyky
Division of Infectious Diseases, Department of Medicine, Stanford University Medical Center, Stanford, CA, USA
Hyaluronan Synthesis Inhibition as a Therapeutic Strategy in Autoimmunity
28-April-2017 : 11:35 – 12:15

Invited Speakers

Suniti Misra
Dept. of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC, USA
Hyaluronan Receptor CD44 in Inflammation
28-April-2017 : 13:45 – 14:05

David M. Leader
Department of Comprehensive Care, Tufts University School of Dental Medicine, Boston, MA 02111, USA
28-April-2017 : 14:05 – 14:25

Mary K. Cowman
Department of Chemical and Biomolecular Engineering, and Department of Orthopaedic Surgery, New York University, New York, NY, USA
Changes in Hyaluronan Content and Size, in Relation to Inflammation
28-April-2017 : 14:25 – 14:45

Ellen Pure
Department of Biomedical Sciences, University of Pennsylvania, Philadelphia, PA, USA
Regulation of Collagen-Rich Matrix Remodeling in Wound Healing,Inflammation and Cancer
28-April-2017 : 14:05 – 14:25

Olgun Guvench
University of New England College of Pharmacy, Portland, ME, USA
Atomic-Resolution Understanding of N-Glycosylation and Protein Conformational Switching that Alter CD44-Hyaluronan Binding
28-April-2017 : 15:05 – 15:25

Gang Li
Division of RIA, Brigham and Women’s Hospital, Boston, MA, USA
From GWAS to Functional SNPs and to Mechanisms
29-April-2017 : 8:30 – 8:50

Mary K. Crow
Division of Rheumatology, Weill Cornell Medical College, New York, NY, USA
Type I Interferon: Pathways Inform Therapeutic Approach
29-April-2016 : 8:50 – 9:10

Montserrat Anguera
University of Pennsylvania, Philadelphia, PA, USA
Maintaining X-Chromosome Inactivation in Female Lymphocytes: a New Therapeutic Target for Female-Biased Autoimmunity
29-April-2017 : 9:10 – 9:30

Keynote Speaker

Sir Marc Feldmann
Kennedy Institute of Rheumatology at the University of Oxford, Oxford, UK
How Can We Get Closer to a Cure for Autoimmunity: Lessons From Rheumatoid Arthritis
29-April-2017 : 9:30 – 10:20

Plenary Session

Ming O. Li
Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
T Cell Metabolism and Autoimmunity
29-April-2017 : 10:40 – 11:20

Invited Speakers

David Naor
Hebrew University, Israel
Anti-Inflammatory Regenerative Activity Of A Cd44-Derived Peptide
29-April-2017 : 11:20 – 11:40

Rina Aharoni
Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel
The Story of Copaxone in The Treatment of Multiple Sclerosis and New Applications
29-April-2017 : 11:40 – 12:00

Charles J. Malemud
Case Western Reserve University School of Medicine, Cleveland, USA
Articular Cartilage as a Target in Autoimmune Disorders
29-April-2017 : 12:00 – 12:20

Plenary Session

Yaron Tomer
Department of Medicine, Montefiore Medical Center, Bronx, NY, USA
Autoimmune Thyroid Diseases: Translating Immunogenetic Mechanisms Into Novel Drug Targets
29-April-2017 : 12:20 – 13:00

Invited Speakers

Vivek Vasdev
Army Hospital Research and Referral, New Delhi, India
Assessment Of Ideal Serum Dilution For Screening Of Antinuclear Antibodies By Indirect Immunofluorescence Method In Diagnosis Of Autoimmune Disorders
29-April-2017 : 13:45 – 14:05